Liying Gao

7 Sudi South Road
Changhongjie, 300192, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Plasma IL-6 level predict the risk of in-hospital mortality in HIV-associated pneumocystis pneumonia.

Plasma IL-6 level predict the risk of in-hospital mortality in HIV-associated pneumocystis pneumonia.

Journal: BMC infectious diseases

Published: May 06, 2025

HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study.

HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study.

Journal: Emerging microbes & infections

Published: June 27, 2024

Rapid Initiation of Antiretroviral Therapy Under the Treat-All Policy Reduces Loss to Follow-Up and Virological Failure in Routine Human Immunodeficiency Virus Care Settings in China: A Retrospective Cohort Study (2016-2022).

Rapid Initiation of Antiretroviral Therapy Under the Treat-All Policy Reduces Loss to Follow-Up and Virological Failure in Routine Human Immunodeficiency Virus Care Settings in China: A Retrospective Cohort Study (2016-2022).

Journal: AIDS patient care and STDs

Published: April 24, 2024

Association between increased CD177 + neutrophils and chronic activation in people living with HIV.

Association between increased CD177 + neutrophils and chronic activation in people living with HIV.

Journal: Chinese medical journal

Published: July 02, 2023

High rates of hepatitis B virus (HBV) functional cure among HIV/HBV coinfected Chinese adults on antiretroviral therapy.

High rates of hepatitis B virus (HBV) functional cure among HIV/HBV coinfected Chinese adults on antiretroviral therapy.

Journal: Chinese medical journal

Published: January 31, 2023

Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome.

Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome.

Journal: Chinese medical journal

Published: December 27, 2022

(5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study.

(5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study.

Journal: The Lancet regional health. Western Pacific

Published: December 02, 2022

Pre-treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China.

Pre-treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China.

Journal: HIV medicine

Published: September 07, 2021

HIV-1 Genetic Diversity and High Prevalence of Pretreatment Drug Resistance in Tianjin, China.

HIV-1 Genetic Diversity and High Prevalence of Pretreatment Drug Resistance in Tianjin, China.

Journal: AIDS research and human retroviruses

Published: June 17, 2020

The Challenge of Potential Drug-Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China.

The Challenge of Potential Drug-Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China.

Journal: Frontiers in pharmacology

Published: February 19, 2020

Characterization of a New HIV-1 CRF01_AE/CRF07_BC Recombinant Virus in Tianjin, China.

Characterization of a New HIV-1 CRF01_AE/CRF07_BC Recombinant Virus in Tianjin, China.

Journal: AIDS research and human retroviruses

Published: May 05, 2018

Trends in the incidence of AIDS and epidemiological features in Tianjin, China from 2005 to 2016.

Trends in the incidence of AIDS and epidemiological features in Tianjin, China from 2005 to 2016.

Journal: Oncotarget

Published: July 07, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026